Gottlieb Scott 4

What Happened

• Scott Gottlieb, a director of UnitedHealth Group (UNH), received an award of 320 deferred stock units on 2026-04-01. The filing reports an acquisition code "A" at $0.00 per unit (total reported cash outlay $0). This is a compensation grant rather than a market purchase or sale.

Key Details

• Transaction date: 2026-04-01; Filing date (Accession): 2026-04-06.
• Transaction type/code: Award/Grant (A); 320 shares/units acquired at $0.00.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: These are deferred stock units granted as regular quarterly director compensation; they vest immediately but must be retained until the director leaves the Board.
• Timeliness: The Form 4 was filed on 2026-04-06 for an Apr 1 transaction, which appears to exceed the usual 2-business-day filing window for Form 4s (so the filing may be late).

Context

• This award is routine director compensation and does not represent an open-market purchase or sale. Deferred stock units typically convert to shares (or pay value) later and are commonly used to compensate non-employee directors; such grants should be viewed as compensation, not a direct signal of buying or selling interest.